Nitric oxide bioavailability and its potential relevance to the variation in susceptibility to the renal and vascular complications in patients with type 2 diabetes
- Kenneth A Earle, MD (k.earle{at}sgul.ac.uk)a,
- Diane Harry, RGNa,
- Mitra Madhavi, MBBSa,
- Karima Zitouni, PhDa and
- Jeffrey Barron, PhDb
- aRoyal Free and University College Medical School, Whittington Hospital, London UK
- bSt Helier Hospital, Carshalton, Surrey, UK
Abstract
Objective: We compared the renal and systemic vascular (renovascular) response to reducing bioavailable nitric oxide in patients with type 2 diabetes without nephropathy of African and Caucasian heritage.
Method: Under euglycaemic conditions, renal blood flow was measured by a constant infusion of paraminohippurate and changes in blood pressure and renal vascular resistance estimated before and after an infusion of L-Ng-monomethyl-l-arginine (L-NMMA).
Results: In the African heritage group there was a significant fall in renal blood flow (Δ − 46.0 mls/min/1.73 m2;p<0.05) and rise in systolic blood pressure (Δ10.0 [2.3 – 17.9] mmHg; p=0.017) which correlated with an increase in renal vascular resistance (r2=0.77; p=0.004).
Conclusions: The renal vasconstrictive response associated with nitric oxide synthase inhibition in this study may be of relevance to the observed vulnerability to renal injury in patients of African heritage.
Footnotes
-
- Received May 13, 2008.
- Accepted October 13, 2008.
- Copyright © American Diabetes Association














